← Back to Patent Explorer
US4304904A Expired / Lapsed US ⏱️ 0.0 years remaining

D-Erythro-2,3-dihydroxy-1-(and 3-) (1-phenyl-1H-pyrazolo[3,4,-b]quinoxalin-3-yl)propyl-β-D-glucopyranoside (and α-D-galactopyranoside) poly(H-sulfate) salts

Assignee: Wyeth Holdings LLC
•
Filing: 1980-03-03
•
Granted: 1981-12-08
•
Expires: 2000-03-03
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract D-Erythro-2,3-dihydroxy-1-(and 3-) (1-phenyl-1H-pyrazolo[3,4-b]quinoxalin-3-yl)propyl-β-D-glucopyranoside (and α-D-galactopyranoside) poly(H-sulfate)salts useful as complement inhibitors.

Inventors

  • 👤 Vijay G. Nair
  • 👤 Seymour Bernstein

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 02:39
CPC Classifications
C; C07; C07H; C07H15/00; C07H15/26

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 31 words
A compound selected from those of the formulae: ##STR3## wherein X is -SO 3 R; wherein R is selected from the group consisting of hydrogen and a pharmaceutically acceptable salt cation.
Claim 2
Dependent Claim 31 words
A compound selected from those of the formulae: ##STR3## wherein X is -SO 3 R; wherein R is selected from the group consisting of hydrogen and a pharmaceutically acceptable salt cation.
Claim 3
Dependent Claim 12 words
The compound according to claim 1, D-erythro-2,3-dihydroxy-3-(1-phenyl-1H-pyrazolo[3,4-b]quinoxalin-3-yl) propyl-α-D-galactopyranoside, hexakis(H-sulfate), hexasalt with trimethylamine.
Claim 4
Dependent Claim 11 words
The compound according to claim 1, D-erythro-2,3-dihydroxy-3-(1-phenyl-1H-pyrazolo[3,4-b]quinoxalin-3-yl) propyl-α-D-galactopyranoside, hexakis(H-sulfate), hexasodium salt.
Claim 5
Dependent Claim 11 words
The compound according to claim 1, D-erythro-2,3-dihydroxy-1-(1-phenyl-1H-pyrazolo[3,4-b]quinoxalin-3-yl)propyl-β-D-glucopyranoside, hexakis(H-sulfate), hexasalt with trimethylamine.
Claim 6
Dependent Claim 10 words
The compound according to claim 1, D-erythro-2,3-dihydroxy-1-(1-phenyl-1H-pyrazolo[3,4-b]quinoxalin-3-yl)propyl-β-D-glucopyranoside, hexakis(H-sulfate), hexasodium salt.

References Cited (Backward Citations)

US3057855A Cited
US4066829A Cited
US4098995A Cited
US4145527A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-12-07 1985-06-08 1985-12-08 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-12-07 1989-06-08 1989-12-08 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-12-07 1993-06-08 1993-12-08 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag